Estrella Immunopharma Stock Buy Hold or Sell Recommendation
| ESLA Stock | 0.99 0.04 3.88% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Estrella Immunopharma is 'Strong Sell'. Macroaxis provides Estrella Immunopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ESLA positions.
Check out Estrella Immunopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide. In addition, we conduct extensive research on individual companies such as Estrella and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Estrella Immunopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Estrella |
Execute Estrella Immunopharma Buy or Sell Advice
The Estrella recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Estrella Immunopharma. Macroaxis does not own or have any residual interests in Estrella Immunopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Estrella Immunopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Estrella Immunopharma Trading Alerts and Improvement Suggestions
| Estrella Immunopharma generated a negative expected return over the last 90 days | |
| Estrella Immunopharma has high historical volatility and very poor performance | |
| Estrella Immunopharma has some characteristics of a very speculative penny stock | |
| Estrella Immunopharma has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Estrella Immunopharma generates negative cash flow from operations | |
| Estrella Immunopharma has a frail financial position based on the latest SEC disclosures | |
| About 72.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Insider Trading |
Estrella Immunopharma Returns Distribution Density
The distribution of Estrella Immunopharma's historical returns is an attempt to chart the uncertainty of Estrella Immunopharma's future price movements. The chart of the probability distribution of Estrella Immunopharma daily returns describes the distribution of returns around its average expected value. We use Estrella Immunopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Estrella Immunopharma returns is essential to provide solid investment advice for Estrella Immunopharma.
| Mean Return | 0.34 | Value At Risk | -10.81 | Potential Upside | 9.89 | Standard Deviation | 6.59 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Estrella Immunopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Estrella Immunopharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Estrella Immunopharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Estrella Immunopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Estrella stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.36 | |
β | Beta against Dow Jones | 0.51 | |
σ | Overall volatility | 6.57 | |
Ir | Information ratio | 0.06 |
Estrella Immunopharma Volatility Alert
Estrella Immunopharma is displaying above-average volatility over the selected time horizon. Estrella Immunopharma is a potential penny stock. Although Estrella Immunopharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Estrella Immunopharma. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Estrella instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Estrella Immunopharma Fundamentals Vs Peers
Comparing Estrella Immunopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Estrella Immunopharma's direct or indirect competition across all of the common fundamentals between Estrella Immunopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Estrella Immunopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Estrella Immunopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Estrella Immunopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Estrella Immunopharma to competition |
| Fundamentals | Estrella Immunopharma | Peer Average |
| Return On Equity | -1.63 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Current Valuation | 15.43 M | 16.62 B |
| Shares Outstanding | 36.18 M | 571.82 M |
| Shares Owned By Insiders | 72.08 % | 10.09 % |
| Shares Owned By Institutions | 0.80 % | 39.21 % |
| Number Of Shares Shorted | 4.87 K | 4.71 M |
| Price To Book | 49.93 X | 9.51 X |
| EBITDA | (7.31 M) | 3.9 B |
| Net Income | (7.31 M) | 570.98 M |
| Total Debt | 180.7 K | 5.32 B |
| Book Value Per Share | 0.02 X | 1.93 K |
| Cash Flow From Operations | (16.07 M) | 971.22 M |
| Short Ratio | 0.93 X | 4.00 X |
| Earnings Per Share | (0.24) X | 3.12 X |
| Beta | 0.41 | -0.15 |
| Market Capitalization | 53.91 M | 19.03 B |
| Total Asset | 4.45 M | 29.47 B |
| Retained Earnings | (19.5 M) | 9.33 B |
| Working Capital | 4.27 M | 1.48 B |
| Net Asset | 4.45 M |
Note: Insider Trading [view details]
Estrella Immunopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Estrella . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 7030.14 | |||
| Daily Balance Of Power | (0.67) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 1.0 | |||
| Day Typical Price | 1.0 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.04) |
About Estrella Immunopharma Buy or Sell Advice
When is the right time to buy or sell Estrella Immunopharma? Buying financial instruments such as Estrella Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Estrella Immunopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Real Estate ETFs Thematic Idea Now
Real Estate ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Real Estate ETFs theme has 66 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Estrella Immunopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Estrella Stock refer to our How to Trade Estrella Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Estrella Immunopharma. If investors know Estrella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Estrella Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Estrella Immunopharma is measured differently than its book value, which is the value of Estrella that is recorded on the company's balance sheet. Investors also form their own opinion of Estrella Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Estrella Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Estrella Immunopharma's market value can be influenced by many factors that don't directly affect Estrella Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Estrella Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Estrella Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Estrella Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.